Prostatype Genomics Navigation
  • THE PROSTATYPE® TEST SYSTEM
    • Prostate cancer and the prognostic challenge
    • Prostatype – The solution
    • Why Prostatype?
    • Resources
      • Publications and Posters
      • White Paper
      • Technical Documents
    • Legal
    • Visit Prostatype® web site
  • ABOUT US
    • Company in brief
    • Mission and Vision
    • History
    • Board of directors
    • Senior management
    • Corporate group structure
    • Advisory Board
    • Careers
  • PRESS & NEWS
  • INVESTOR RELATIONS
    • Reports and presentations
    • Analyst coverage
    • Financial calendar
    • Share and shareholder information
    • Financial goals
    • Corporate governance
    • IPO
    • IR contact
    • Certified Adviser
  • Contact
  • THE PROSTATYPE® TEST SYSTEM
    • Prostate cancer and the prognostic challenge
    • Prostatype – The solution
    • Why Prostatype?
    • Resources
      • Publications and Posters
      • White Paper
      • Technical Documents
    • Legal
    • Visit Prostatype® web site
  • ABOUT US
    • Company in brief
    • Mission and Vision
    • History
    • Board of directors
    • Senior management
    • Corporate group structure
    • Advisory Board
    • Careers
  • PRESS & NEWS
  • INVESTOR RELATIONS
    • Reports and presentations
    • Analyst coverage
    • Financial calendar
    • Share and shareholder information
    • Financial goals
    • Corporate governance
    • IPO
    • IR contact
    • Certified Adviser
  • Contact


reports and presentations


Interim reports


Interim accounts 2019-07-01  -  2020-12-31 (English)

Interim accounts 2019-07-01  -  2020-12-31 (Swedish)

Interim accounts 2019-07-01 – 2020-06-30

Interim report 2020-07-01 – 2020-09-30

Auditor's report Interim report 2020-07-01 - 2020-09-30

Interim accounts 2021-01-01 – 2021-03-31 (English)

Interim accounts 2021-01-01 – 2021-03-31 (Swedish)

Interim accounts 2021-04-01 – 2021-06-30 (English)

Interim accounts 2021-04-01 – 2021-06-30 (Swedish)

Interim accounts 2021-07-01 – 2021-09-30 (English)

Interim accounts 2021-07-01 – 2021-09-30 (Swedish)

Auditor’s report Interim Accounts 2021-07-01 – 2021-09-30

Interim accounts 2022-01-01 – 2022-03-031 (Swedish)

Interim accounts 2022-01-01 – 2022-03-031 (English)

Year-end report


Bokslutskommuniké & Q4 Rapport 2021

Year-end Report & Q4 2021

Annual reports


Annual report 2021 (Svenska)
Annual report 2021 (English)
Annual report 2019/2020 (Svenska)
Annual report 2019/2020 (English)
Annual report 2019
Annual report 2018
Annual report 2017

Prospectus/Memorandum


EU-tillväxtprospekt Prostatype Genomics

Prostype Genomics – Tilläggsprospekt

Nyttjande av teckningsoptioner av serie to 1

Exercise of warrants of series to 1

Anmälningssedel - TO 1 SV

Subscription form- TO 1 EN

Presentations


Other reports


Audit report

Contact

Industrivägen 19
171 48 Solna
+46 (0)8-20 87 00‬‬
info@prostatypegenomics.com

Prostatype.se

Menu

THE PROSTATYPE® TEST SYSTEM
ABOUT US
PRESS & NEWS
INVESTOR RELATIONS
CONTACT

EIT Health

Subscribe

    Hemsida skapad av Webb & SEO Byrå Hjalmar&Company

    SITEMAP I Privacy Policy

    A Message from Prostatype Genomics AB Regarding COVID-19. In response to the COVID-19 outbreak the World Health Organization (WHO) declared a pandemic on Wednesday 11th March 2020.

    Read more!
    X